The National Institute of Pharmaceutical Education and Research (NIPER) Guwahati is emerging as a significant player in shaping India’s pharmaceutical and healthcare sectors. As an Institute of National Importance, NIPER Guwahati is dedicated to advancing pharmaceutical education, research, and innovation. With a strong focus on research, entrepreneurship, and collaborations, the institute is addressing key healthcare challenges and making substantial contributions to pharmaceutical sciences.
Established in 2008 under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers (Government of India), NIPER Guwahati was conceived to provide leadership in pharmaceutical sciences not only within India but also in Southeast Asia, South Asia, and Africa.
Cutting-Edge Research and Development
Research excellence is at the core of NIPER Guwahati’s initiatives. The institute focuses on drug development, nanotechnology, and biotechnology, which are crucial for developing new therapies and improving drug delivery systems. With state-of-the-art research facilities, students and faculty push the boundaries of pharmaceutical sciences. Its advanced laboratories and 10 Centres of Excellence facilitate the exploration of novel drug formulations and innovative solutions to complex health problems.
Incubation Centers Supporting Entrepreneurship
A standout feature of NIPER Guwahati is its commitment to nurturing entrepreneurship and transforming research into marketable ventures. The institute has established two incubation centres: Bio-NEST and the Atal Incubation Centre (AIC).
Bio-NEST has supported 37 entrepreneurs over the past five years, helping them establish startups, file six patents, and raise over ₹3.6 crore in funding. The centre specializes in biotech and healthcare startups, including initiatives focusing on traditional medicine products from Northeast India, offering scientific validation for global market entry.
Notable faculty-led startups supported by Bio-NEST
- Suriya Eye Products Therapeutics Pvt. Ltd. (Prof. S. Tamilvanan)—Innovating Janus nanocapsules for dry eye syndrome management (TRL 2 to TRL 4).
- Nutriciana Healthcare Pvt. Ltd. (Dr. Sanjay K. Banerjee)—Developing nutritional products for malnutrition from Musa balbisiana (TRL 3 to TRL 5).
- Dr. Sethi’s Laboratories Pvt. Ltd. (Dr. Kalyan Sethi)—Specializing in scaling up high-yield lutein production from marigold flowers (TRL 3 to TRL 5).
- Spraarsh Therapeutics Pvt. Ltd. (Dr. Deepak Bhardwaj)—Developing bioactive herbonanoceuticals for tumour cell photothermal ablation (TRL 3 to TRL 5).
- Maa Kamakhya Pharmaceuticals Pvt. Ltd. (Dr. Pramod Kumar)—Low-cost optimization for developing ginger oleoresin and gingerol (TRL 3 to TRL 5).
Atal Incubation Centre (AIC): Fostering Innovation
The Atal Incubation Centre (AIC) NIPER Guwahati Foundation, launched in 2023, is supported by the Atal Innovation Mission (AIM), NITI Aayog. It provides mentorship, seed funding, lab facilities, and business support to startups in pharmaceuticals, healthcare, biotechnology, agriculture, and water management.
AIC has supported 23 startups, including six women-led ventures, and facilitated the filing of two patents. It has also supported four MSMEs (Micro, Small, and Medium Enterprises), helping them scale operations and promote inclusivity in the entrepreneurial ecosystem.
Notable innovations supported under AIC NIPER Guwahati Foundation
- Maa Kamakhya Pharmaceuticals Pvt. Ltd. (Dr. Pramod Kumar) – Golden Milk Powder Production, which received FSSAI approval.
- PlebC Pvt. Ltd. (Dr. Krishna Prasad) – TORUS – Tele-Operated Robotic Ultrasound System.
- Tribal Factory (Mr. Krishnarjun Das)—Empowering communities through low-GI rice and its products.
- Alona Life Sciences Pvt. Ltd. (Dr. Subhalakshmi Ghosh)—Sell the Scale.
- Graduate Farmer (Mr. Bapan Das)—Low-cost Azolla-based poultry feed pellet (antibiotic-free).
Looking Ahead: A Future of Innovation
NIPER Guwahati’s commitment to pharmaceutical research, fostering entrepreneurship, and supporting regional development positions it as a key driver of innovation in India. Through cutting-edge research, incubation programs, and international collaborations, NIPER Guwahati is shaping the future of pharmaceutical sciences and healthcare delivery.
As global demand for innovative healthcare solutions rises, NIPER Guwahati is poised to lead in drug development, biotechnology, and health solutions. By nurturing creativity, collaboration, and commercialization, the institute is empowering future scientists, entrepreneurs, and innovators who will redefine global healthcare.
Also Read: NIELIT pioneering India’s Digital Transformation
Conclusion
NIPER Guwahati is playing a pivotal role in shaping the future of India’s pharmaceutical industry. Its focus on research, entrepreneurship, and regional empowerment is driving innovation and contributing to a healthier future for India and beyond. Through its continued commitment to excellence, NIPER Guwahati is making a lasting impact on India’s healthcare ecosystem while promoting progress, innovation, and economic growth.
Views Expressed by: Prof. USN Murty, Director, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter, Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
